Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Yes on Issue 2: Ohioans Will Vote Yes after Seeing Ballot Language

Ohio Taxpayers for Lower Drug Prices
Posted on: 18 Aug 17

The Yes on Issue 2 campaign believes Ohioans will vote yes this November after reading the ballot language approved today to lower drug prices for 4 million Ohioans, including 164,000 children, and save taxpayers $400 million.

“Voters in Ohio are well-informed, smart and angry at the greedy drug companies that have been price-gouging the sick and suffering, and putting profits before patients,” said Dennis Willard, spokesperson for the Yes on Issue 2 campaign. “The language is simple and straightforward just like our plan to lower drug prices for 4 million Ohioans and save taxpayers $400 million a year.”

A yes vote would, according to the ballot language, “require the state of Ohio, including its state departments, agencies and entities, to not pay more for prescription drugs than the price paid by the United States Department of Veterans Affairs.”

“This program has worked for veterans for 25 years. A yes vote on Issue 2 will protect veterans and lower drug prices,” Willard said. “Voters are learning that the men in the shadows writing checks to the no to lower drug prices campaign are greedy drug company CEOs who are ashamed to be associated with the campaign of lies and distortions they are running to protect their obscene profits.”

The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson.

You can learn more by visiting or following us on Facebook and Twitter.

Paid for by Ohio Taxpayers for Lower Drug Prices

View source version on

Business Wire

Last updated on: 18/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.